Literature DB >> 21956470

Pristine C(60) fullerenes inhibit the rate of tumor growth and metastasis.

S V Prylutska1, A P Burlaka, Yu I Prylutskyy, U Ritter, P Scharff.   

Abstract

AIM: To estimate the impact of C(60) fullerene aqueous solution (C(60)FAS) on the rate of transplanted malignant tumor growth and metastasis.
METHODS: Lewis lung carcinoma was transplanted into С57Bl/6J male mice. Conventional methods for the evaluation of antitumor and antimetastatic effects have been used.
RESULTS: The C(60)FAS at low single therapeutic dose of 5 mg/kg inhibited the growth of transplanted malignant tumor (antitumor effect) and metastasis (antimetastatic effect): the maximum therapeutic effect was found to be of 76.5% for the tumor growth inhibition; the increase of animal life span by 22% was found; the metastasis inhibition index was estimated as 48%.
CONCLUSION: It was found that water-soluble pristine С(60) fullerenes efficiently inhibit the transplanted malignant tumor growth and metastasis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21956470

Source DB:  PubMed          Journal:  Exp Oncol        ISSN: 1812-9269


  11 in total

1.  Interceptor effect of C60 fullerene on the in vitro action of aromatic drug molecules.

Authors:  Galyna B Skamrova; Ivan Laponogov; Anatoly S Buchelnikov; Yuriy G Shckorbatov; Svitlana V Prylutska; Uwe Ritter; Yuriy I Prylutskyy; Maxim P Evstigneev
Journal:  Eur Biophys J       Date:  2014-04-20       Impact factor: 1.733

2.  Protective effect of reduced glutathione C60 derivative against hydrogen peroxide-induced apoptosis in HEK 293T cells.

Authors:  Jin Huang; Chi Zhou; Jun He; Zheng Hu; Wen-Chao Guan; Sheng-Hong Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

3.  Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.

Authors:  Ran Tao; Chengzhang Wang; Yin Lu; Changwei Zhang; Hao Zhou; Hongxia Chen; WenJun Li
Journal:  Int J Nanomedicine       Date:  2020-04-22

4.  Nanoparticles of carbon allotropes inhibit glioblastoma multiforme angiogenesis in ovo.

Authors:  Marta Grodzik; Ewa Sawosz; Mateusz Wierzbicki; Piotr Orlowski; Anna Hotowy; Tomasz Niemiec; Maciej Szmidt; Katarzyna Mitura; André Chwalibog
Journal:  Int J Nanomedicine       Date:  2011-11-25

5.  C60 fullerene as synergistic agent in tumor-inhibitory Doxorubicin treatment.

Authors:  Svitlana Prylutska; Iryna Grynyuk; Olga Matyshevska; Yuriy Prylutskyy; Maxim Evstigneev; Peter Scharff; Uwe Ritter
Journal:  Drugs R D       Date:  2014-12

6.  Complex of C60 Fullerene with Doxorubicin as a Promising Agent in Antitumor Therapy.

Authors:  Svitlana V Prylutska; Larysa M Skivka; Gennadiy V Didenko; Yuriy I Prylutskyy; Maxim P Evstigneev; Grygoriy P Potebnya; Rostyslav R Panchuk; Rostyslav S Stoika; Uwe Ritter; Peter Scharff
Journal:  Nanoscale Res Lett       Date:  2015-12-29       Impact factor: 4.703

7.  C60 Fullerene as Promising Therapeutic Agent for the Prevention and Correction of Skeletal Muscle Functioning at Ischemic Injury.

Authors:  D M Nozdrenko; D O Zavodovskyi; T Yu Matvienko; S Yu Zay; K I Bogutska; Yu I Prylutskyy; U Ritter; P Scharff
Journal:  Nanoscale Res Lett       Date:  2017-02-14       Impact factor: 4.703

8.  Comparative Analysis of the Antineoplastic Activity of C60 Fullerene with 5-Fluorouracil and Pyrrole Derivative In Vivo.

Authors:  O V Lynchak; Yu I Prylutskyy; V K Rybalchenko; O A Kyzyma; D Soloviov; V V Kostjukov; M P Evstigneev; U Ritter; P Scharff
Journal:  Nanoscale Res Lett       Date:  2017-01-05       Impact factor: 4.703

9.  Comparison of anti-angiogenic properties of pristine carbon nanoparticles.

Authors:  Mateusz Wierzbicki; Ewa Sawosz; Marta Grodzik; Marta Prasek; Slawomir Jaworski; André Chwalibog
Journal:  Nanoscale Res Lett       Date:  2013-04-26       Impact factor: 4.703

10.  A nanocomplex of C60 fullerene with cisplatin: design, characterization and toxicity.

Authors:  Svitlana Prylutska; Svitlana Politenkova; Kateryna Afanasieva; Volodymyr Korolovych; Kateryna Bogutska; Andriy Sivolob; Larysa Skivka; Maxim Evstigneev; Viktor Kostjukov; Yuriy Prylutskyy; Uwe Ritter
Journal:  Beilstein J Nanotechnol       Date:  2017-07-20       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.